Market research on the tissue and hygiene industry. Our reports f...
Market research on the tissue and hygiene industry. Our reports feature standardised and cross-comparable total market sizes, market and brand share data, distribution and trends.
Rx/reimbursement adult incontinence saw growth in Israel in 2023. The National Insurance Institute of Israel encourages the elderly to remain at home in their communities. For this reason, it grants long-term care benefits to those who choose to stay…
Rx/reimbursement adult incontinence continued to experience steady volume and current value growth in Brazil in 2023, despite economic challenges. However, the category faced significant hurdles, particularly in health units, where a shortage of…
For nearly 40 years. the Spanish Public Health system has included adult incontinence protection in the list of Rx/reimbursement medical products. These products can be purchased through e-commerce and in health and beauty specialists with the…
Rx/reimbursement adult incontinence in France continued its positive growth trend in 2023, in terms of both volume and current value sales, benefitting from the essential nature of the category’s products. There was a small deceleration in the first…
Rx/reimbursement adult incontinence recorded strong growth in current value terms in 2023 continuing the trend of the previous year. However, this was mainly due to prevailing inflationary pressures, as rising raw material, production and transport…
In 2023, rx/reimbursement adult incontinence in Germany continued to record positive value growth, particularly given the increased costs of products and the impact of a high inflation rate. Nevertheless, volume growth decreased marginally, in a…
The category of Rx/reimbursement adult incontinence experienced growth in both volume and value terms in 2023 in Slovenia, driven primarily by healthcare settings. As the elderly population continues to increase, more individuals are seeking…
The growth of Rx/reimbursement adult incontinence in Slovakia remained stable in 2023, as consumers tend to use these products for a long time. Compared to retail, products prescribed by the doctor are fully reimbursed by an insurance company, and…
In 2023, Rx/reimbursement adult incontinence was on the rise in Hungary, fuelled by the ageing population, which led to increased and ongoing use of the products. In a time of rising inflation, consumers were increasingly attracted to reimbursement…
An ageing population in need of constant care is driving growth of Rx/reimbursement adult incontinence products in Switzerland among both elderly and temporary post-partum incontinence sufferers. Many Swiss consumers are visiting their doctors more…
The demand for Rx (prescription) adult incontinence products in Turkey experienced robust growth in 2023, driven by a surge in volume sales. Open-tape adult diapers designed for heavy incontinence dominated the market, with the Social Security…
Volume sales of Rx/reimbursement adult incontinence in Serbia remained stable in 2023. The ageing population is the main driver of category sales, as the elderly tend to experience incontinence issues later in life. In tandem, rising inflation and…
The year 2023 witnessed a notable increase in demand for RX/reimbursement adult incontinence products in Belgium, spurred by several key drivers. Firstly, Belgium's ageing population continued to fuel sustained demand for such products. Additionally,…
The National Institute of Social Services for Retirees and Pensioners (PAMI) is the public institution charged with providing healthcare coverage to elderly people in Argentina, a remit that includes the distribution of Rx/reimbursement adult…
As with retail adult incontinence, an ageing population remained the key driver of Rx/reimbursement sales in Croatia in 2023, with the category recording solid volume and current value growth in the year. Incontinence products are considered medical…
Rx/reimbursement adult incontinence in Australia saw volume and current value growth in 2023. The policy and pre-budget submission by the Continence Foundation of Australia for 2023-2024 continues to tackle the stigma and restrictions associated with…
Unit price points for Rx/reimbursement adult incontinence experienced a high but moderating spike in Norway in 2023. This increase can be attributed to inflationary pressures, including rising input costs such as energy, materials, labour, and…
RX/reimbursement adult incontinence in Lithuania experienced significant growth in 2023, largely driven by state support and legislative changes. The decrease in prices for Rx products by 20-30% from July 1, 2023, provided a substantial boost to…
In 2023, the demand for Rx/reimbursement adult incontinence witnessed continued growth in Estonia, with both value and volume experiencing an upward trajectory. This growth trend persisted despite the ongoing challenges associated with limited…